GlucoTrack (GCTK): Aggregate Business Value

GlucoTrack Inc. - graphic logo of issuer GCTK

GlucoTrack, Inc. (GCTK) develops glucose monitoring devices, yet cash flows remain volatile due to the product's go-to-market process. Development relies on a fabless model, where component manufacturing is outsourced to US contractors. The market dynamics reflected in the quotes on GURU.Markets, where the Enterprise Value stands at 2.87, confirm the company's dependence on existing investments in the absence of regular operating revenue.

GCTK GlucoTrack Inc. Real Price to Acquire Entire Company (11/23/2025 - 10/28/2026)
Original product of GlucoTrack, Inc.

For GlucoTrack, Inc. (GCTK), which utilizes a fabless model with outsourced production, market valuation is often subject to volatility driven by sensor-related news. By analyzing enterprise value dynamics, an investor can determine the actual acquisition price of the asset, where market capitalization is adjusted for net debt, allowing them to filter out speculative noise and identify the true financial stability of the company in a full takeover scenario.

Who GlucoTrack, Inc. competes with

DXCM - Real Price to Acquire Entire Company|Real Price to Acquire Entire Company Penumbra Corp PEN|NOVT: Aggregate Business Value|HAE: Total Company Value|Enterprise Value inspiresleep.com|PROCEPT BioRobotics Corporation (PRCT) - Real Price to Acquire Entire Company|Aggregate Business Value CONMED Corp|Pulse Corp (PLSE) - Enterprise Value|Value Adjusted for Debt and Cash InMode MD (INMD)|PMI: Enterprise Value|surmodics.com - Total Enterprise Value|Total Company Value Senseonics Holdings (SENS)|NPCE - Value Adjusted for Debt and Cash|TCMD: Enterprise Value|SNWV (SANUWAVE Health Inc) - Enterprise Value|Total Company Value Outset Medical, Inc. OM|Full Business Value Electromed Inc|LENSAR - Enterprise Value|Total Enterprise Value AVITA Medical Inc. RCEL|Real Price to Acquire Entire Company PROF (Profound Medical)|BDMD - Enterprise Value|Real Price to Acquire Entire Company EDAP Medical EDAP|APYX - Aggregate Business Value|icecure-medical.com - Enterprise Value|Pulmonx (LUNG) - Company Buyout Price|Enterprise Value TELA|Real Price to Acquire Entire Company CytoSorbents Corp. (CTSO)|Sensus Healthcare, Inc. (SRTS) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash ZYXI (zynex.com)|electroCore - Total Company Value|Real Price to Acquire Entire Company Vicarious Surgical Inc RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd) - Enterprise Value|ICU - Total Enterprise Value|Enterprise Value iridex.com|Intelligent Bio Solutions Inc. (INBS) - Business Value|XAIR: Enterprise Value|Company Buyout Price Profusa Inc.|Enterprise Value SSKN (STRATA Skin Sciences)|Real Price to Acquire Entire Company nanovibronix.com (NAOV)|Enterprise Value VERO (Venus Concept Inc.)|nuwellis.com - Enterprise Value|AEMD - Total Company Value|Asensus Surgical, Inc. (ASXC) - Total Company Value|Real Price to Acquire Entire Company Avinger, Inc AVGR|BioSig (BSGM) - Value Adjusted for Debt and Cash|Enterprise Value CUTR (Cutera, Inc.)|Total Enterprise Value KNW|NARI: Total Company Value|Full Takeover Company Value Nevro Corp NVRO|Real Price to Acquire Entire Company RSLS (ReShape Lifesciences Inc.)|Enterprise Value Silk Road Medical Inc SILK